Man dies in three-vehicle crash south of Winchester

Published Jun 28, 2024  •  Last updated 2 days ago  •  1 minute read

OPP
OPP Photo by Postmedia

A 50-year-old Morrisburg man is dead after a three-vehicle collision south of Winchester on Thursday afternoon.

The collision at around 3:30 p.m. involved two SUVs and a transport truck on Bank Street between Winchester and Williamsburg, said OPP.

The initial investigation found the transport was heading south in the southbound lane when a northbound SUV moved into the southbound lane, resulting in a head-on collision, said police. The second SUV then collided with the wreckage.

The driver of one SUV was pronounced dead at the scene. The transport driver was taken to hospital with minor injuries. The other SUV driver was checked out by paramedics, but had no serious injuries.

The investigation continues.

Recommended from Editorial

  1. Jason Lamarche as a candidate in Vancouver municipal elections in 2011.
Glenn Baglo/Postmedia

    Man charged with threatening to kill Coun. Stéphanie Plante is a former candidate for Vancouver mayor

  2. Dr. Brian Nadler faces four first-degree murder charges.  Brian Nadler/LinkedIn

    The trial of a doctor accused of killing four elderly patients starts Tuesday. Here’s what you need to know

Ottawa Citizen

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Elizabeth Payne, David Pugliese, Andrew Duffy, Bruce Deachman and others. Plus, food reviews and event listings in the weekly newsletter, Ottawa, Out of Office.
  • Unlimited online access to Ottawa Citizen and 15 news sites with one account.
  • Ottawa Citizen ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.
  • Support local journalism.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Elizabeth Payne, David Pugliese, Andrew Duffy, Bruce Deachman and others. Plus, food reviews and event listings in the weekly newsletter, Ottawa, Out of Office.
  • Unlimited online access to Ottawa Citizen and 15 news sites with one account.
  • Ottawa Citizen ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.
  • Support local journalism.

REGISTER / SIGN IN TO UNLOCK MORE ARTICLES

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account.
  • Share your thoughts and join the conversation in the comments.
  • Enjoy additional articles per month.
  • Get email updates from your favourite authors.

Sign In or Create an Account

or

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
HER3-Targeted Drug Active in Advanced/Metastatic Breast Cancer thumbnail

HER3-Targeted Drug Active in Advanced/Metastatic Breast Cancer

Oncology/Hematology > Breast Cancer — Durable responses across all three major subtypes of breast cancer by Charles Bankhead, Senior Editor, MedPage Today October 10, 2023 Last Updated October 13, 2023 An antibody-drug conjugate (ADC) targeting HER3 produced objective responses in as many as 43% of patients with advanced breast cancer, a prospective clinical trial showed.
Read More
Schisandra Chinensis: Unveiling Its Medicinal Wonders thumbnail

Schisandra Chinensis: Unveiling Its Medicinal Wonders

Schisandra chinensis is native to northern China and Manchuria in northeastern China. In Japan it is called gomishi, and in China wuzweizi (five flavours fruit). Schisandra has been said to have the perfect blend of the five main flavours: salty, sweet, sour, bitter and pungent or spicy. In Traditional Chinese Medicine, schisandra is one of
Read More
Review covers progress in immunotherapy for esophageal cancer thumbnail

Review covers progress in immunotherapy for esophageal cancer

Multiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could cement ICI-based immunotherapy as the new standard systemic treatment option for esophageal cancer. Credit: Hecheng Li of Department of Thoracic Surgery, Ruijin Hospital Affiliated to Shanghai Jiao Tong
Read More
Index Of News
Total
0
Share